RETRACTION: MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathway

IF 4.5 2区医学 Q1 ONCOLOGY

Cancer Science Pub Date : 2024-07-22 DOI:10.1111/cas.16269

{"title":"RETRACTION: MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathway","authors":"","doi":"10.1111/cas.16269","DOIUrl":null,"url":null,"abstract":"Retraction: T.-Q. Yang, X.-J. Lu, T.-F. Wu, D.-D. Ding, Z.-H. Zhao, G.-L. Chen, X.-S. Xie, B. Li, Y.-X. Wei, L.-C. Guo, Y. Zhang, Y.-L. Huang, Y.-X. Zhou, and Z.-W. Du, “MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathway,” Cancer Science 105 no. 3 (2014): 265–271. https://doi.org/10.1111/cas.12351.The above article, published online on 13 January 2014 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Masanori Hatakeyama; the Japanese Cancer Association; and John Wiley and Sons Ltd. The journal had previously published a correction regarding duplicated portions of Figure 4a on 24 May 2022. Following publication of this correction, the journal was made aware that not all duplicated portions of Figure 4a had been replaced. Additionally, concerns were raised of splicing in Figure 2d and image duplications in Figures 2d, 3d, and 4c. The authors did not respond to inquiries from the publisher regarding these concerns. and did not provide the requested original images and data. Therefore, the data reported in this article are considered unreliable and the journal must issue a retraction. The authors did not respond to our notice of retraction.","PeriodicalId":9580,"journal":{"name":"Cancer Science","volume":"115 9","pages":"3200"},"PeriodicalIF":4.5000,"publicationDate":"2024-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cas.16269","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Science","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cas.16269","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Retraction: T.-Q. Yang, X.-J. Lu, T.-F. Wu, D.-D. Ding, Z.-H. Zhao, G.-L. Chen, X.-S. Xie, B. Li, Y.-X. Wei, L.-C. Guo, Y. Zhang, Y.-L. Huang, Y.-X. Zhou, and Z.-W. Du, “MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathway,” Cancer Science 105 no. 3 (2014): 265–271. https://doi.org/10.1111/cas.12351.

The above article, published online on 13 January 2014 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Masanori Hatakeyama; the Japanese Cancer Association; and John Wiley and Sons Ltd. The journal had previously published a correction regarding duplicated portions of Figure 4a on 24 May 2022. Following publication of this correction, the journal was made aware that not all duplicated portions of Figure 4a had been replaced. Additionally, concerns were raised of splicing in Figure 2d and image duplications in Figures 2d, 3d, and 4c. The authors did not respond to inquiries from the publisher regarding these concerns. and did not provide the requested original images and data. Therefore, the data reported in this article are considered unreliable and the journal must issue a retraction. The authors did not respond to our notice of retraction.

查看原文本刊更多论文

返回：MicroRNA-16 通过抑制 BCL2 和核因子-κB1/MMP9 信号通路抑制胶质瘤细胞的生长和侵袭。

撤回：T.-Q.Yang, X.-J. Lu, T.-F.Wu, D.-D. Ding, Z.-H.Ding, Z.-H. Zhao, G.-L. Chen, X.-S.Zhao, G.-L. Chen, X.-S.Xie, B. Li, Y.-X.Wei, L.-C. Guo, Y. Zhang, Y.-X.Guo, Y. Zhang, Y.-L. Huang, Y.-X.Zhou，and Z.-W. Du，"MicroRNA-16 inhibited MicroRNADu, "MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathway," Cancer Science 105 no. 3 (2014): 265-271. https://doi.org/10.1111/cas.12351。上述文章于 2014 年 1 月 13 日在线发表于 Wiley Online Library (wileyonlinelibrary.com)，经杂志主编 Masanori Hatakeyama、日本癌症协会和 John Wiley and Sons Ltd.（约翰-威利父子有限公司）协商，该文章已被撤回。该期刊曾于 2022 年 5 月 24 日就图 4a 中重复的部分发表了更正。更正发表后，本刊了解到图 4a 的重复部分并未全部替换。此外，图 2d 中的拼接以及图 2d、3d 和 4c 中的图像重复也引起了关注。作者没有回复出版商关于这些问题的询问，也没有提供所要求的原始图像和数据。因此，这篇文章中报告的数据被认为是不可靠的，期刊必须发表撤稿声明。作者没有回应我们的撤稿通知。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cancer Science 医学-肿瘤学

自引率

3.50%

发文量

406

审稿时长

2 months

期刊介绍： Cancer Science (formerly Japanese Journal of Cancer Research) is a monthly publication of the Japanese Cancer Association. First published in 1907, the Journal continues to publish original articles, editorials, and letters to the editor, describing original research in the fields of basic, translational and clinical cancer research. The Journal also accepts reports and case reports. Cancer Science aims to present highly significant and timely findings that have a significant clinical impact on oncologists or that may alter the disease concept of a tumor. The Journal will not publish case reports that describe a rare tumor or condition without new findings to be added to previous reports; combination of different tumors without new suggestive findings for oncological research; remarkable effect of already known treatments without suggestive data to explain the exceptional result. Review articles may also be published.